由于移植物抗宿主病病情的严重性，临床医生在治疗中，往往缺乏细致诊断，就使用大剂量的类固醇抑制免疫细胞的反应。
Because of the severity of GVHD, clinicians often begin treatment — high doses of steroids to suppress the immune response — in the absence of a concrete diagnosis.
结果：辅助性肝脏移植患者免疫抑制剂浓度相对较低，排斥反应次数少，强度低。
Results:Immunosuppressive agent concentration was lower, rejection was less and intensity was milder in these patients.
结论异种移植发生延迟性排斥反应时，P选择素和ICAM - 1均有表达，可以作为判断异种移植免疫抑制治疗效果的指标之一。
Conclusion the expression of P-selectin and ICAM-1 in xenografts was increased during delayed xenograft rejection, which is of value in judging the effect of immunosuppression in xenotransplantation.
另外，科研人员应继续开发和利用新型共刺激靶点及免疫抑制剂，这可能对消除记忆性T细胞的反应有关键作用。
Additionally, research efforts should continue to identify and manipulate new costimulatory targets and immunosuppressants, which may be key to abrogating memory T-cell responses.
结果辅助性肝脏移植患者免疫抑制剂浓度相对较低，排斥反应次数少，强度低。
Results Immunosuppressive agent concentration was lower with mild intensity of rejection in these patients.
ELISA法检测小鼠免疫血清的抗体效价，以血凝抑制试验测定其免疫反应性。
The antibody titers in sera of the immunized mice were detected by ELISA and the immunoreactivity was measured by hemagglutination inhibition test.
目的：探讨FK- 5 0 6抑制高危角膜移植免疫排斥反应临床应用的可行性及有效性。
Objective: To evaluate the clinical probability and efficacy of FK-506 on suppressing cornea transplantation rejection.
在新型免疫抑制剂应用下，急性排斥反应具有表现不典型、难治性排斥反应比例高等特点。
With novel immunosuppressive agents coming into clinical use, manifestations of acute rejection are not typical and refractory rejection is increasing.
在新型免疫抑制剂应用下，急性排斥反应具有表现不典型、难治性排斥反应比例高等特点。
With novel immunosuppressive agents coming into clinical use, manifestations of acute rejection are not typical and refractory rejection is increasing.
应用推荐